• Remission Rates, Not Disease Origin, Drive Quality of Life Scores in Cushing’s Patients, Study Suggests
  • What Caregivers Should Know
  • Japan Endocrine Society Proposes Revised Diagnostic Criteria for Adrenal Subclinical Cushing’s Syndrome
  • Phase 2 Trial Testing Seliciclib for Cushing’s Disease Is Recruiting Participants
  • Dealing with Misdiagnoses
  • Fluorescent Metabolite Might Help Surgeons Remove Pituitary Tumors, Study Says
  • NIH Agency Pioneers Collaborative Research into Rare Diseases
  • Steroid Inhibitors in Cushing’s Led to Spontaneous Remission of Ectopic Tumors in Case Study
  • Fluasterone Receives Orphan Drug Status for the Treatment of Hallmark Signs of Cushing’s Syndrome
  • You’re Worth the Fight
  • Stronger MRI Enables Precise Spotting of Tumor Location in Cushing’s Disease Patients, Case Report Shows
  • Strongbridge Starts Another Phase 3 Trial of Its Cushing’s Therapy